Le Lézard
Classified in: Health, Business
Subjects: SVY, LIC

Jeff Kovatch and JK Consulting Group Hold Seminar in Cary, NC on Sales in Dentistry


CARY, N.C., Jan. 27, 2020 /PRNewswire-PRWeb/ -- Jeff Kovatch recently held a seminar at Riccobene Associates Family Dentistry. His training, "The Science Behind Emotional Intelligence in Sales" reviewed how to discover and meet patients' expectations while driving their motivation for treatment. Attendees included over 50 dentists, office managers, executives, and support staff.

Riccobene Associates Family Dentistry proudly serves quality dental care from over 25 locations across North Carolina. Partnering with Kovatch and JK Consulting Group, they held a training event to not only improve their patient experience, but expand their business as a whole. First and foremost a "sales" training, the concepts covered during their recent seminar are also considered essential across the business, from successfully crafting an advertising campaign, to gaining buy-in on a complex treatment plan.

Kovatch has served as the Marketing Director for Riccobene Associates in the past, helping them expand to 10 new locations and better serve their North Carolina community. Now with over three decades of experience growing practices and businesses across the country, he brings new communication and sales insights to this team of dentists.

"There are many skills required to be a good salesperson," says Kovatch. "Confidence, motivation, passion, and drive are all important, but perhaps the most important skill of all is emotional intelligence."

The top 10 percent of dental professionals differentiate themselves by uncovering their patients' true needs. Kovatch lectured on how to help patients and clinicians understand these needs and visualize them before meeting them. By using the Self-Visualization Method, patients are able to see how their health and their lives will benefit after treatment; meeting and often surpassing their objectives.

Diving deep into a patient's desires is just the first step, though. Kovatch's training included how to uncover barriers and solve obstacles that prevent treatment plan acceptance. He discussed one way of solving the common financial barrier is by providing creative funding strategies and flexible financing options.

Focused on practice growth management, JK Consulting Group has particular experience providing the consulting, marketing, and sales support single dental practices, as well as group DSOs, need to increase their conversion rates and grow. A team of experienced private equity professionals and Industry Operating Advisors, they also work outside of the dental field helping middle-market companies through any stage of their life cycle.

Those interested in scheduling Jeff Kovatch to speak, provide a private training, or partner with JK Consulting Group to grow their business can call 973-809-5466 or learn more at http://www.jkconsultinggroup.com.

About JK Consulting Group

JK Consulting Group brings over three decades of experience partnering with small, mid-sized, and large companies across the country. Jeff Kovatch, founder and CEO, has proven experience in the healthcare, hospitality, and dental fields and leverages his expertise as a multi-talented business growth visionary with each new partnership. JK Consulting Group takes a hands-on approach to consulting whether through mergers and acquisitions, marketing and sales, facilitation of investments, or tailored coaching and training regimens. Those interested in partnering with an innovative and experienced consultant can call 973-809-5466 or visit http://www.jkconsultinggroup.com to learn more.

 

SOURCE JK Consulting Group


These press releases may also interest you

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...



News published on and distributed by: